Roche Posts Higher Sales on Growth Across Pharma, Diagnostics Units

Roche reiterated its full-year guidance and said it is prepared to launch its giredestrant breast-cancer pill later this year.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。